Five Seeger Weiss Attorneys Named to Inaugural Edition of Lawdragon 500 X – The Next Generation

Seeger Weiss is honored to announce that Lawdragon named five of our attorneys to its inaugural edition of 500 X – The Next Generation list, including partners Parvin Aminolroaya, Chris Ayers, and Caleb Seeley, as well as attorneys Nigel Halliday and Max Kelly. The list features attorneys who “represent the tried and true paths worn […]

July 10, 2023

Lawdragon 500 X post

Seeger Weiss is honored to announce that Lawdragon named five of our attorneys to its inaugural edition of 500 X – The Next Generation list, including partners Parvin Aminolroaya, Chris Ayers, and Caleb Seeley, as well as attorneys Nigel Halliday and Max Kelly. The list features attorneys who “represent the tried and true paths worn by those who came before them – clerking for prestigious judges, anchoring law reviews. Then have blown down the walls of private practice, amassing courtroom victories, leading deals and protecting IP and civil rights.”

This honor follows several Seeger Weiss partners who, earlier this year, were named to Lawdragon’s 2023 Leading Plaintiff Financial LawyersPlaintiff Consumer LawyersLeaders in Environmental Law, and Leading Lawyers in America lists.” The selection methodologies can be found at the bottom of the articles linked above. No aspect of these advertisements has been approved by the Supreme Court of New Jersey.

Lawdragon’s selection methodology is performed through independent journalistic research and submissions. Decisions are carefully made based on factors including research of top verdicts and settlements, peer recognition, and interviews with lawyers nationwide. The selection methodology can be found here. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More